All content for This Week in Addiction Medicine from ASAM is the property of American Society of Addiction Medicine and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
A podcast source for news briefings on the top stories in the field of addiction medicine.
Lead: Co-involvement of stimulants with opioids in North America: A 'silent epidemic’
This Week in Addiction Medicine from ASAM
7 minutes 19 seconds
3 months ago
Lead: Co-involvement of stimulants with opioids in North America: A 'silent epidemic’
Co-involvement of stimulants with opioids in North America: A 'silent epidemic’
Plos Mental Health
The opioid epidemic unfolded in three distinct waves, with the latest being deaths attributed to illegally manufactured synthetic opioids. Using U.S. and Canadian data, this study reviews evidence for a 'silent epidemic' alongside the opioid epidemic that is characterized by the co-ingestion of stimulants including methamphetamine and cocaine leading to an increasing number of deaths. Trends for stimulant and opioid use were analyzed using Joinpoint regression and public interest in the substances was assessed via Google Trends. While stimulant use and its role in deaths are rising, public interest in stimulants has declined since its peak in 2004-05. Co-use leads to more deaths than either drug alone. Urgent strategies are needed to reduce harm and raise awareness among health professionals, policymakers, and the public about the dangers of stimulant-opioid co-use.
Read this issue of the ASAM Weekly
Subscribe to the ASAM Weekly
Visit ASAM
This Week in Addiction Medicine from ASAM
A podcast source for news briefings on the top stories in the field of addiction medicine.